Trever Burgon, PhD
Dr. Burgon is a nationally recognized leader in healthcare strategy and has worked extensively with senior health system leaders across the country on projects ranging from demand forecasting and value-based payment structures to clinical technology assessment and cancer center development. In addition, Trever speaks frequently at national conferences on issues on of quality and value in healthcare. Before joining QURE, Trever served as Vice President at Sg2 (now a division of MedAssets), a health care analytics and intelligence company. At Sg2, Trever led the firm’s Center for Clinical Technology as well as the Oncology Strategy team. Trever holds a PhD from Stanford University in Microbiology and Immunology and received his BS from Brigham Young University.